These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8784801)

  • 61. Effects of immunosuppressive treatment on interleukin-15 and interleukin-15 receptor α expression in muscle tissue of patients with polymyositis or dermatomyositis.
    Zong M; Loell I; Lindroos E; Nader GA; Alexanderson H; Hallengren CS; Borg K; Arnardottir S; McInnes IB; Lundberg IE
    Ann Rheum Dis; 2012 Jun; 71(6):1055-63. PubMed ID: 22267334
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Presence of HTLV-I proviral DNA in central nervous system of patients with HTLV-I-associated myelopathy.
    Kira J; Itoyama Y; Koyanagi Y; Tateishi J; Kishikawa M; Akizuki S; Kobayashi I; Toki N; Sueishi K; Sato H
    Ann Neurol; 1992 Jan; 31(1):39-45. PubMed ID: 1543349
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Human T-lymphocyte virus type I (HTLV-I)-induced myeloneuropathy in rats: oligodendrocytes undergo apoptosis in the presence of HTLV-I.
    Ohya O; Ikeda H; Tomaru U; Yamashita I; Kasai T; Morita K; Wakisaka A; Yoshiki T
    APMIS; 2000 Jun; 108(6):459-66. PubMed ID: 11028810
    [TBL] [Abstract][Full Text] [Related]  

  • 64. HTLV-I-associated myelopathy: clinicopathologic correlation with localization of provirus to spinal cord.
    Bhigjee AI; Wiley CA; Wachsman W; Amenomori T; Pirie D; Bill PL; Windsor I
    Neurology; 1991 Dec; 41(12):1990-2. PubMed ID: 1745362
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Familial transmission and minimal sequence variability of human T-lymphotropic virus type I (HTLV-I) in Zaire.
    Liu HF; Vandamme AM; Kazadi K; Carton H; Desmyter J; Goubau P
    AIDS Res Hum Retroviruses; 1994 Sep; 10(9):1135-42. PubMed ID: 7826698
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Human T-cell lymphotropic virus Type I (HTLV-I) as a cause of progressive myelopathy].
    Portegies P; Goudsmit J
    Ned Tijdschr Geneeskd; 1991 Jul; 135(29):1302-6. PubMed ID: 1865933
    [No Abstract]   [Full Text] [Related]  

  • 67. Increased HTLV-I proviral DNA in HTLV-I-associated myelopathy: a quantitative polymerase chain reaction study.
    Kira J; Koyanagi Y; Yamada T; Itoyama Y; Goto I; Yamamoto N; Sasaki H; Sakaki Y
    Ann Neurol; 1991 Feb; 29(2):194-201. PubMed ID: 2012389
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Temporal lesions and widespread involvement of white matter associated with multi-organ inflammatory disease in human T-lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Mendes GB; Kalil RS; Rosadas C; de Freitas MR; Puccioni-Sohler M
    Int J Infect Dis; 2014 Aug; 25():1-3. PubMed ID: 24815740
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anatomical distribution of HTLV-I proviral sequence in an autopsy case of HTLV-I associated myelopathy: a polymerase chain reaction study.
    Sueyoshi K; Goto M; Johnosono M; Sato E; Shibata D
    Pathol Int; 1994 Jan; 44(1):27-33. PubMed ID: 8025646
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [HTLV-I associated myelopathy (HAM) complicated with chronic polymyositis].
    Tanaka T; Takagi A; Kojima S; Goto J; Tanaka M
    Rinsho Shinkeigaku; 1989 Jan; 29(1):102-7. PubMed ID: 2743679
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HTLV-I induced myeloneuropathy in WKAH rats: apoptosis and local activation of the HTLV-I pX and TNF-alpha genes implicated in the pathogenesis.
    Ohya O; Tomaru U; Yamashita I; Kasai T; Morita K; Ikeda H; Wakisaka A; Yoshiki T
    Leukemia; 1997 Apr; 11 Suppl 3():255-7. PubMed ID: 9209357
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Plasma cells in muscle in inclusion body myositis and polymyositis.
    Greenberg SA; Bradshaw EM; Pinkus JL; Pinkus GS; Burleson T; Due B; Bregoli L; O'Connor KC; Amato AA
    Neurology; 2005 Dec; 65(11):1782-7. PubMed ID: 16344523
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [HTLV-I retrovirus in Chile: study on 140 neurological patients].
    Cartier L; Araya F; Castillo JL; Verdugo R; Mora C; Gajdusek DC; Gibbs CJ
    Rev Med Chil; 1990 Jun; 118(6):622-8. PubMed ID: 1775782
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Correlation of HTLV-1 Tax genetic diversity with HTLV-1 associated myelopathy/tropical spastic paraparesis progression and HTLV-1a genotypes in an HTLV-1 endemic region in Argentina.
    Iñiguez AM; Gastaldello R; Otsuki K; Balangero M; Carvalho Costa F; Remondegui C; Paula Vicente AC; Gallego S
    J Med Virol; 2010 Aug; 82(8):1438-41. PubMed ID: 20572090
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Triple Therapy with Prednisolone, Pegylated Interferon and Sodium Valproate Improves Clinical Outcome and Reduces Human T-Cell Leukemia Virus Type 1 (HTLV-1) Proviral Load, Tax and HBZ mRNA Expression in Patients with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis.
    Boostani R; Vakili R; Hosseiny SS; Shoeibi A; Fazeli B; Etemadi MM; Sabet F; Valizade N; Rezaee SA
    Neurotherapeutics; 2015 Oct; 12(4):887-95. PubMed ID: 26174324
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection.
    Kubota R; Kawanishi T; Matsubara H; Manns A; Jacobson S
    J Immunol; 1998 Jul; 161(1):482-8. PubMed ID: 9647259
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Expression of human T lymphotropic virus type 1 (HTLV-1) tax/rex gene in fresh bronchoalveolar lavage cells of HTLV-1-infected individuals.
    Higashiyama Y; Katamine S; Kohno S; Mukae H; Hino S; Miyamoto T; Hara K
    Clin Exp Immunol; 1994 May; 96(2):193-201. PubMed ID: 7910532
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Human T cell leukemia virus Type I (HTLV-I) infection induces greater expansions of CD8 T lymphocytes in persons with HTLV-I-associated myelopathy/tropical spastic paraparesis than in asymptomatic carriers.
    Ureta-Vidal A; Pique C; Garcia Z; Dehée A; Tortevoye P; Désiré N; Gessain A; Chancerel B; Gout O; Lemonnier FA; Cochet M
    J Infect Dis; 2001 Mar; 183(6):857-64. PubMed ID: 11237801
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Expression of FAP-1 (Fas-associated phosphatase) and resistance to Fas-mediated apoptosis in T cell lines derived from human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis patients.
    Arai M; Kannagi M; Matsuoka M; Sato T; Yamamoto N; Fujii M
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):261-7. PubMed ID: 9491917
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Tropical spastic paraparesis and HTLV-1 associated myelopathy: clinical, epidemiological, virological and therapeutic aspects.
    Gessain A; Mahieux R
    Rev Neurol (Paris); 2012 Mar; 168(3):257-69. PubMed ID: 22405461
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.